✦ LIBER ✦

The role of biologic therapies in the management of systemic vasculitis

✍ Scribed by A.T. Chan; O. Floßmann; C. Mukhtyar; D.R.W. Jayne; R.A. Luqmani

Book ID: 113481799
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 204 KB
Volume: 5
Category: Article
ISSN: 1568-9972
DOI: 10.1016/j.autrev.2006.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted Biologic Approaches to the Trea

Targeted Biologic Approaches to the Treatment of Systemic Vasculitis

✍ Andreea Coca; Jennifer H. Anolik 📂 Article 📅 2008 🏛 Humana Press Inc 🌐 English ⚖ 156 KB

Current State of Biologicals in the Mana

Current State of Biologicals in the Management of Systemic Vasculitis

✍ PETER LAMPRECHT; ANDREAS TILL; JÖRG STEINMANN; PEER M. ARIES; WOLFGANG L. GROSS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

The Role of the Endothelium in Systemic

The Role of the Endothelium in Systemic Vasculitis

✍ Caroline O.S. Savage; Stephen P. Cooke 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 511 KB

The Role of the Clinical Nurse Specialis

The Role of the Clinical Nurse Specialist in the Assessment and Management of Biologic Therapies

✍ Susan M. Oliver 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

The role of cellular immunity in systemi

The role of cellular immunity in systemic vasculitis

✍ P. W. MATHIESON; D. B. G. OLIVEIRA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Transcending conventional therapies: The

Transcending conventional therapies: The role of biologic and other novel therapies

✍ Dr. William J. Sandborn 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

Biologic and other novel therapies targeted to specific pathogenic processes offer the potential for improved treatment outcomes in patients with Crohn's disease and alteration of the course of the disease. Therapies targeted to tumor necrosis factor alpha (TNF-alpha) include anti-TNF-alpha monoclon